Exited to share the first results from the TOMBOLA trial presented at #ESMO24 by @JBjerggaard. We used tumor informed (WES; ddPCR) ctDNA analysis to guide Atezolizumab treatment after cystectomy using longitudinally collected blood samples.
Key findings:
•CtDNA-negative patients: 98% RFS at 1 year
•~50% are ctDNA-positive
•CtDNA-positive patients: 75% RFS at 1 year
•55% of Atezolizumab-treated patients cleared ctDNA & have no evidence of disease
Conclusion: ctDNA shows promise for treatment de-escalation (ctDNA-) and patient selection for adjuvant therapy (ctDNA+)
@Karin_Dem@IverNordentoft@SiaLindskrog @TrineStrandgaa1 @cancer_dk@DCCCcancer@CtdnaDK@AUHdk@AarhusUni
New paper published in @IntJCanc addressing the selection of mutations to be used as ctDNA markers 🧬📃
Find the article here: https://t.co/D3IvpTMk2T
#ctDNA#CancerResearch@moma_dk
Så er der snart frist, hvis du vil have del i DCCC’s pulje! Send din ansøgning senest d. 22. april kl. 08 – læs mere: https://t.co/2WK4wRSr6j #samarbejdeomkræft#dkforsk
In these days @CNAPS2024 is taking place in Graz, Austria. The center is represented with both participants and presentations about circulating tumor DNA 🩸🧬
Thank you for organizing this exciting conference, #CNAPS2024#ctDNA#CancerResearch
Gratis AUH-foredrag - også online - om strålebehandling og kræft-DNA i blodet ved @KSeiersen fra @DCPTprotons og @ClausLindbjerg fra @moma_dk den 27. februar kl 16
https://t.co/U5W9t4btAR
@CtdnaDK
BLODPRØVE KAN HJÆLPE MED PRIORITERING AF KRÆFTBEHANDLING
Kræft-DNA i blodet hos patienter med de meste aggressive kræftformer stiger meget hurtigt.
Blodprøver kan være et redskab til prioritering af operationskapacitet på kræftområdet.
https://t.co/l5VB3BTVLH
📷Jens Løgstrup
1000 tak @ClausLindberg fra @moma_dk for endnu engang at stille op lære fra dig af din store viden om #ctDNA 🙏🏼 det var en fantastisk god og meget pædagogisk gennemgang - spot-on til #ungekræftlæger til vores jule-webinar her til aften 🎄
📢 Our newest study on >800 CRC patients is now out 🧬
Read how:
1) Serial ctDNA = powerful recurrence predictor ⏳
2) Rapid ctDNA growth = detrimental to survival 📈
3) Personalized digital PCR = clinically practical for MRD analysis💡
��� Read more in @AnnalsofOncology! 📰
Thank you for two inspiring days at the Annual Meeting 2023 last week!
Focus at the meeting:
👉Updates on ctDNA research DK
👉The way from trial to clinical implementation of ctDNA
👉ctDNA RECIST as a tool for monitoring therapy response
👉Collaboration and networking across DK
Yesterday @ClausLindbjerg and Kåre Gotschalck visited Go'morgen Danmark on TV2 to tell about the promising research in ctDNA🧬
Funding from #KnækCancer has enabled the establishment of the national ctDNA Center and the research🙌
Find the piece at TV2 play
#ctDNA#gotv2dk
Welcome Jakob Skou Pedersen as a speaker at #cnaps2024, Prof. of Bioinformatics at @moma_dk. His current research focuses on the development of statistical methods for circulating tumor DNA (#ctDNA) detection and analysis of single-cell data.
Welcome @ClausLindbjerg, director of the “National Danish Research Centre for circulating tumor DNA guided treatment”, as a speaker at #cnaps2024. His research focuses on translation of basic molecular cancer knowledge into clinical tools.
GUIDE-MRD, a new initiative about:
👉Defining reference standards for ctDNA testing
👉Clinical validation of ctDNA-based MRD detection assays
👉Integrating ctDNA testing into clinical practice
👉therefore, improving patient outcomes
@ClausLindbjerg is part of the consortium
👩🎓PhD defence Thur September 21st at 10 AM
Amanda Johansen @amanda_fbj will defend her thesis "Blood-based detection of disease in patients with colorectal cancer" at @HealthAarhusUni.
Read more here:
https://t.co/D0W3koJGjy
#ctDNA#colorectalcancer
📸 AU Photo/Lars Kruse
Open Postdoc position at the Medical University of Graz, Austria!
👉There is an open Postdoc position within GUIDE.MRD – an EU project to benchmark and validate available ctDNA assays for MRD detection.
#ctDNA#Postdoc
Til Danske Kræftforskningsdage 2023 fortæller @Amanda_fbj om sin forskning i cirkulerende tumor DNA
Tillykke med at være en af de syv, der modtager prisen ”Exceptional Young Scientist Abstract”! 🎉
#DKD2023#ctDNA#CancerResearch@moma_dk
Kan vi forudsige tilbagefald af kræft med en blodprøve? Det dykker @amanda_fbj ned i til #DKD2023, når hun i sessionen ’Aktuel Dansk Kræftforskning i Rampelyset’ går på scenen. Her vil hun få prisen "Exceptional Young Scientist Abstract". Tillykke! #SamarbejdeOmKræft#dkforsk